Holen Sie sich die Stockscreener-App
25.73
2.35%
0.59
Vorhandelsmarkt:
25.85
0.12
+0.47%
Schlusskurs vom Vortag:
$25.14
Offen:
$24.97
24-Stunden-Volumen:
1.04M
Relative Volume:
0.65
Marktkapitalisierung:
$1.45B
Einnahmen:
$308.05M
Nettoeinkommen (Verlust:
$-95.57M
KGV:
-14.96
EPS:
-1.72
Netto-Cashflow:
$-58.34M
1W Leistung:
+9.68%
1M Leistung:
-0.23%
6M Leistung:
-25.89%
1J Leistung:
-51.48%
1-Tages-Spanne:
$24.80
$25.97
1-Wochen-Bereich:
$23.54
$26.01
52-Wochen-Spanne:
$19.35
$66.85
Procept Biorobotics Corp Stock (PRCT) Company Profile
Firmenname
Procept Biorobotics Corp
Sektor
Branche
Telefon
(650) 232-9832
Adresse
150 BAYTECH DRIVE, SAN JOSE
Compare PRCT vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
25.73 | 1.42B | 308.05M | -95.57M | -58.34M | -1.72 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-06 | Eingeleitet | Robert W. Baird | Neutral |
| 2026-02-26 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2026-02-26 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-12-12 | Eingeleitet | UBS | Buy |
| 2025-12-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-09-02 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-07-09 | Eingeleitet | Stephens | Overweight |
| 2025-07-07 | Eingeleitet | Oppenheimer | Perform |
| 2024-12-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-11-14 | Eingeleitet | Jefferies | Hold |
| 2023-08-11 | Eingeleitet | Piper Sandler | Overweight |
| 2023-05-31 | Eingeleitet | William Blair | Outperform |
| 2022-10-31 | Eingeleitet | BTIG Research | Neutral |
| 2022-10-25 | Eingeleitet | Truist | Buy |
| 2022-09-02 | Eingeleitet | Wells Fargo | Overweight |
| 2022-07-15 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-06-23 | Eingeleitet | B. Riley Securities | Buy |
| 2021-10-11 | Eingeleitet | BofA Securities | Buy |
| 2021-10-11 | Eingeleitet | Cowen | Outperform |
| 2021-10-11 | Eingeleitet | Goldman | Neutral |
| 2021-10-11 | Eingeleitet | Guggenheim | Buy |
| 2021-10-11 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Procept Biorobotics Corp Aktie (PRCT) Neueste Nachrichten
Wells Fargo lowers Procept BioRobotics target after weak Q4 performance - MSN
Assessing PROCEPT BioRobotics (PRCT) Valuation After Strong Q3 2025 Update And 2026 Outlook - Sahm
Chicago Capital LLC Has $37.47 Million Holdings in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics (PRCT) price target decreased by 37.60% to 33.58 - MSN
PROCEPT BioRobotics (PRCT) Projected to Post Earnings on Thursday - MarketBeat
PROCEPT BioRobotics (PRCT) Is Up 7.5% After Raising 2026 Revenue Outlook And Sharpening Growth Focus - simplywall.st
PROCEPT BioRobotics (PRCT) Earnings Transcript - The Motley Fool
PROCEPT BioRobotics (PRCT) Financial Results Conference Transcript - Bitget
Baillie Gifford & Co. Purchases 157,147 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics to Report First Quarter 2026 Financial Results on April 29, 2026 - 富途牛牛
PROCEPT BioRobotics (PRCT) strengthens its case with expanding system base - MSN
PROCEPT BioRobotics® to Report First Quarter 2026 Financial Results on April 29, 2026 - GlobeNewswire
PRCT Drops 8.6% as Uncertain Indicators and Soft Fundamentals Persist - Bitget
Morgan Stanley Maintains PROCEPT BioRobotics (PRCT) Overweight Recommendation - MSN
A Look At PROCEPT BioRobotics (PRCT) Valuation After New European Aquablation Guideline Upgrade - simplywall.st
Oppenheimer Upgrades PROCEPT BioRobotics (PRCT) - MSN
PRCT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Will Aquablation’s Strong EU Guideline Backing Reshape PROCEPT BioRobotics’ (PRCT) Long-Term Narrative? - Sahm
PROCEPT BioRobotics Corporation $PRCT Shares Acquired by SG Americas Securities LLC - MarketBeat
Prosight Management, LP's PROCEPT BioRobotics Corp(PRCT) Holding History - GuruFocus
PRCT Stock Price, Quote & Chart | PROCEPT BIOROBOTICS CORP (NASDAQ:PRCT) - ChartMill
PRCT: $50.2M ADJUSTED EBITDA LOSS VS. $35M PROJECTED -- LEVI & KORSINSKY, LLP INVESTIGATES - MarketScreener
Short Covering: Is PROCEPT BioRobotics Corporation a turnaround story2026 Patterns & Real-Time Buy Signal Alerts - baoquankhu1.vn
PROCEPT BioRobotics: An Undervalued Surgical Robotics Growth Story (NASDAQ:PRCT) - Seeking Alpha
Truist Lowers PT on PROCEPT BioRobotics Corporation (PRCT) to $50 From $64, Keeps a Buy Rating - MSN
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Given Average Rating of "Hold" by Brokerages - marketbeat.com
PROCEPT BioRobotics (NASDAQ:PRCT) Stock Price Up 6.6%Still a Buy? - MarketBeat
Vanguard Realigns Reporting; PROCEPT BioRobotics (PRCT) Beneficial Ownership 0% - Stock Titan
EAU Upgrade Puts Aquablation And PROCEPT BioRobotics In Focus - Yahoo Finance
PROCEPT BioRobotics (PRCT) Strengthens Its Case with Expanding System Base - Insider Monkey
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PROCEPT BioRobotics CorporationPRCT - PR Newswire
PRCT: GUIDED $325.5M, HID PRICING HEADWIND -- LEVI & KORSINSKY, LLP INVESTIGATES - GlobeNewswire
How Investors May Respond To PROCEPT BioRobotics (PRCT) Winning Strong EAU Backing For Aquablation - simplywall.st
PROCEPT BioRobotics outlines $325.5M 2025 revenue target amid leadership transition and margin expansion - MSN
PROCEPT BioRobotics Corporation (PRCT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
JPMorgan Chase & Co. Cuts Stake in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages PROCEPT BioRobotics Corporation (PRCT) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Sonder Capital Closes its Second Fund and Announces Participation from Major Healthcare Systems - marketscreener.com
User - The Chronicle-Journal
Bronstein, Gewirtz & Grossman, LLC Is Investigating PROCEPT BioRobotics Corporation (PRCT) And Encourages Shareholders to Connect - ACCESS Newswire
A Look At PROCEPT BioRobotics (PRCT) Valuation After Aquablation Wins Strong European Guideline Backing - simplywall.st
Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Chemed (CHE) and PROCEPT BioRobotics (PRCT) - The Globe and Mail
Europe's top urology guide strongly backs Aquablation for BPH - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against PROCEPT BioRobotics Corporation (PRCT) And Encourages Shareholders to Reach Out - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages PROCEPT BioRobotics Corporation (PRCT) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Alaleh Nouri, EVP at Procept Biorobotics, sells $139k in PRCT stock - Investing.com Australia
Finanzdaten der Procept Biorobotics Corp-Aktie (PRCT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
1.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):